| Category | BioTech |
| Phone | 604-926-5657 |
| Employees | |
| Founded | 2007 |
| TOTAL | $19.7M |
| VENTURE FUNDING TOTAL | $19.7M |
| Series A, 9/11 Inventages Venture Capital Investment Inc. Working Opportunity Fund | €13.5M |
MSI Methylation Sciences Inc. operates as a biotechnology company. The company develops and markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. MSI Methylation Sciences Inc. was founded in 2007 and is based in West Vancouver, Canada.
